The Institute for Glycomics’ malaria vaccine researchers are one step closer to human trials for a malaria vaccine that can be freeze-dried.
Griffith launches human trials for a vaccine against Streptococcus A, the germ that causes rheumatic fever.
A new experimental drug to treat sepsis has now entered the next stage of clinical trials in patients in Australia...
Griffith University’s Institute for Glycomics has received a $5 million philanthropic donation from the International Leducq Foundation to further the development of a Strep A vaccine.
Griffith University researchers have developed a new vaccine in pre-clinical studies to treat human babesiosis, a tick-transmitted disease closely related to malaria.
This is the fourth of a series of five blogs on COVID 19 and human rights, focusing on the timeline...
Human clinical trial success of new drug candidate to treat viral arthritis caused by mosquito-borne infections.
Queensland College of Art’s Dr Julie Fragar is taking a fine art lens to criminal justice with her work Next Witness.
Researchers offer free trials to help reduce burden of osteoporotic fractures in older women.
Initial success in human clinical trials has given hope for the next stage in the development of a new malaria vaccine.
